Overview


According to FutureWise analysis the market for analgesics in 2023 is US$ 32.54 billion, and is expected to reach US$ 55.17 billion by 2031 at a CAGR of 6.80%.

Analgesics are drugs capable of relieving pain but not causing loss of consciousness. Paracetamol and nonsteroid anti-inflammatory drugs (NSAIDs) are a significant group of analgesics capable of producing analgesic and anti-inflammatory effects. Anti-inflammatory analgesics reduce inflammation, and opioid analgesics change how the brain perceives despair. Many types of analgesics are available, from pills and liquids to gels and patches you apply to your body. Some analgesics can be purchased over the counter, and others are available by prescription only. The mechanism action of these drugs is on the central nervous system. They are apt to inhibit cyclooxygenases and thereby decrease the production of prostaglandin. 

Many anti-inflammatory and analgesic drugs share similar side effects. Hypersensitivity responses to aspirin-like medications are thought to arise due to an accumulation of prostaglandins after the pathways break down prostaglandins are blocked. These responses can be destructive when strong anti-inflammatory compounds are administered. Inhibition of prostaglandin synthesis can lead to other serious side effects, such as the development of peptic ulcers and reduced ability of platelets in the blood to aggregate and form clots. The latter effect, however, has given aspirin an added use as a prophylactic antithrombotic drug to reduce chances of cardiac or cerebral vascular thrombosis, the formation of a lump in a blood vessel in the heart or brain. Some aspirin-like analgesics also have specific toxic effects like liver damage occasionally after administering acetaminophen, and renal toxicity is sometimes seen with NSAIDs. Aspirin, taken in overdose, can cause deafness, ear ringing, diarrhea, nausea, and headache, which disappear when the dose is reduced or discontinued.

FutureWise Market Research has published a report that provides an insightful analgesics market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, analgesics market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Bayer AG
  • Novartis AG
  • GlaxoSmithKline PLC
  • Pfizer Inc.
  • Johnson and Johnson
  • Reckitt Benckiser (RB)
  • Endo Pharmaceuticals
  • Bristol-Myers Squibb
  • Eli Lilly and Company
  • Sanofi S.A.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Analgesics Market:

  • In January 2021-Pfizer partnered with Premier, an American healthcare improvement company. Following this cooperation, the companies would offer five essential medications to healthcare practitioners to help them fulfill the immediate and long-term demands for necessary medications necessary for a range of patient care interventions.

  • In June 2021-Bayer developed its business in India by establishing its Consumer Health division. 

Increased incidence of chronic diseases, such as tuberculosis (TB), cancer, cardiovascular diseases, and arthritis, is expected to drive the analgesics market growth. In addition, patients have a substantial rise due to infectious diseases such as gastrointestinal, respiratory, and neurology. The increase in these diseases, in turn, increases the demand for painkillers, which is foreseen to drive the analgesics market share further. Moreover, an increase in funding from private & government organizations for the development of pharmaceutical manufacturing segments and a rise in R&D activities for the advancement of analgesic products surge the growth of the analgesics industry. Furthermore, strategic collaborations and advancement in medical drug development creates new opportunity in analgesics growth market. Producers purchase smaller businesses in leading analgesic medicine to acquire a competitive advantage and strengthen their market position. These purchases aid organizations in boosting regionally and gaining technological expertise in new product research and development. For example, WCG purchased Analgesic Solutions, LLC in 2019. WCG seeks to grow and position itself as a market leader in the analgesic sector by leveraging Analgesic Solutions, LLC's outstanding R&D expertise. This will further create new market opportunities during the forecast period of 2022-2029. Therefore, the increasing use of biologics for treating inflammatory and neuropathic pain obstructs the growth of the analgesics market. Biologics are drugs produced from living organisms, including several components derived from humans, animals, or microorganisms. These drugs may contain proteins, modified human hormones, or cells that produce substances that suppress or activate parts of the immune system. Biologics can provide greater efficacy than analgesics, which provide effective pain relief and are thus widely used nowadays. For example, the FDA approved Pfizer and Lilly for developing Tanezumab, a biologics medicine.

By Drug Class

  • Opioids
  • Non-steroidal anti-inflammatory drugs (NSAIDs)
  • Local Anesthetics
  • Acetaminophen

By Pain Type

  • Surgical pain
  • Cancer pain
  • Neuropathic pain
  • Other types of pain

By Distribution Channel

  • Hospital pharmacies
  • Retail pharmacies
  • Drug stores
  • Clinics
  • Others

By Route of Administration

  • Oral
  • Intravenous
  • Rectal
  • Transdermal
  • Topical

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Owing to the increased demand for non-opioid drugs, the presence of key players and the rising demand for painkillers significantly contribute to the market growth across the region. The development of research and development activities in the healthcare industry positively influences the market growth.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Analgesics Market By Drug Class, By Pain Type, By Distribution Channel, By Route of Administration and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Analgesics Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Analgesics Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Analgesics Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Analgesics Market, By Drug Class Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Opioids
        2. Non-steroidal anti-inflammatory drugs (NSAIDs)
        3. Local Anesthetics
        4. Acetaminophen

  • 8.   Analgesics Market, By Pain Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Surgical pain
        2. Cancer pain
        3. Neuropathic pain
        4. Other types of pain

  • 9.   Analgesics Market, By Distribution Channel Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospital pharmacies
        2. Retail pharmacies
        3. Drug stores
        4. Clinics
        5. Others

  • 10.   Analgesics Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral
        2. Intravenous
        3. Rectal
        4. Transdermal
        5. Topical

  • 11.   North America Analgesics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Analgesics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Analgesics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Analgesics Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Bayer AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Novartis AG
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. GlaxoSmithKline PLC
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Pfizer Inc.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Johnson and Johnson
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Reckitt Benckiser (RB)
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Endo Pharmaceuticals
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Bristol-Myers Squibb
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Eli Lilly and Company
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Sanofi S.A.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client

Related Market

Topical Analgesics Market

Read More

OTC Analgesic Market

Read More

Non-opioid Analgesic Patch Market

Read More
Partner

Our Clients